Memorial Sloan Kettering Cancer Center (MSK) is one of the world’s premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs. The blending of research with patient care is at the heart of everything we do. The institution is a comprehensive cancer center whose purposes are the treatment and control of cancer, the advancement of biomedical knowledge through laboratory and clinical research, and the training of scientists, physicians and other health care workers.
A postdoctoral position is available for a highly motivated and experienced researcher with a background in molecular pharmacology, and/or cancer biology. Our research group is studying the basis for resistance to targeted therapy in cancer with a focus on breast cancer and developing new therapeutic strategies to overcome drug resistance.
The ideal candidate should have:
● PhD or MD
● Strong laboratory and analytical skills
Please send CV, a letter outlining your current and future interest, a description of past research experience and accomplishments, selected reprints of publications, expected availability date and names/contact information of three references via email to:
Sarat Chandarlapaty, MD, PhD
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.